Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.

CONCLUSION: The prevalence of NNRTI- PDR was above the critical level of 10% suggested by the Global Action Plan on HIV Drug Resistance. The distribution of drug resistance mutations was similar to that seen in previous studies from the region, and further supports the introduction of integrase inhibitors in first-line treatment in Malawi. Furthermore, our findings underline the need for continued PDR surveillance and pharmacovigilance in Sub-Saharan Africa. PMID: 32434561 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32434561?dopt=Abstract

Source: AIDS Research and Therapy - May 19, 2020 Category: Infectious Diseases Authors: Neuhann F, de Forest A, Heger E, Nhlema A, Scheller C, Kaiser R, Steffen HM, Tweya H, Fätkenheuer G, Phiri S Tags: AIDS Res Ther Source Type: research